Transgenic reporter mice as tools for studies of transplantability and connectivity of dopamine neuron precursors in fetal tissue grafts

Progress in Brain Research

Volumn 175, Issue , 2009, Pages 53-79

  H Thompson, Lachlan ^a   Björklund, Anders ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LUND UNIVERSITY   (Sweden)

Author keywords

cell sorting; cell therapy; GFP; Parkinson's disease; regeneration; transplantation; ventral mesencephalon

Indexed keywords

GREEN FLUORESCENT PROTEIN;

BRAIN DEVELOPMENT; CELL SURVIVAL; CELL THERAPY; CELL TYPE; DOPAMINERGIC NERVE CELL; FETAL TISSUE GRAFT; GENE EXPRESSION; HUMAN; MESENCEPHALON; MOTOR PERFORMANCE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RELIABILITY; REPORTER GENE; REVIEW; SAFETY; TISSUE GRAFT; TRANSGENIC MOUSE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; FETAL STEM CELLS; HUMANS; MESENCEPHALON; MICE; MICE, TRANSGENIC; NEURONS; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

EID: 67849130967     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17505-2     Document Type: Review

References (122)

1. Aguayo A.J., Bjorklund A., Stenevi U., and Carlstedt T. Fetal mesencephalic neurons survive and extend long axons across peripheral nervous system grafts inserted into the adult rat striatum. Neuroscience Letters 45 (1984) 53-58
2. Andersson E., Jensen J.B., Parmar M., Guillemot F., and Bjorklund A. Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133 (2006) 507-516
3. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124 (2006) 393-405
4. Arts M.P., Groenewegen H.J., Veening J.G., and Cools A.R. Efferent projections of the retrorubral nucleus to the substantia nigra and ventral tegmental area in cats as shown by anterograde tracing. Brain Research Bulletin 40 (1996) 219-228
5. Barroso-Chinea P., Cruz-Muros I., Aymerich M.S., Rodriguez-Diaz M., Afonso-Oramas D., Lanciego J.L., et al. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. The European Journal of Neuroscience 21 (2005) 1815-1827
6. Bayer S.A., Wills K.V., Triarhou L.C., and Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Experimental Brain Research 105 (1995) 191-199
7. Bentlage C., Nikkhah G., Cunningham M.G., and Bjorklund A. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Experimental Neurology 159 (1999) 177-190
8. Bjorklund A., and Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends in Neuroscience 30 (2007) 194-202
9. Bjorklund A., and Lindvall O. Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Research 83 (1975) 531-537
10. Bjorklund A., and Lindvall O. Dopamine-containing systems in the CNS. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of chemical neuroanatomy (1984), Elsevier, Amsterdam 55-123
11. Bjorklund A., Nornes H., and Gage F.H. Cell suspension grafts of noradrenergic locus coeruleus neurons in rat hippocampus and spinal cord: reinnervation and transmitter turnover. Neuroscience 18 (1986) 685-698
12. Bjorklund A., Stenevi U., Schmidt R.H., Dunnett S.B., and Gage F.H. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiologica Scandinavica. Supplementum 522 (1983) 9-18
13. Bjorklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 2344-2349
14. Bolam J.P., Freund T.F., Bjorklund A., Dunnett S.B., and Smith A.D. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Experimental Brain Research 68 (1987) 131-146
15. Brecknell J.E., Haque N.S., Du J.S., Muir E.M., Fidler P.S., Hlavin M.L., et al. Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat. Neuroscience 71 (1996) 913-925
16. Brizard M., Carcenac C., Bemelmans A.P., Feuerstein C., Mallet J., and Savasta M. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease. Neurobiology of Disease 21 (2006) 90-101
17. Bustos G., Abarca J., Campusano J., Bustos V., Noriega V., and Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Research. Brain Research Reviews 47 (2004) 126-144
18. Canty A.J., and Murphy M. Molecular mechanisms of axon guidance in the developing corticospinal tract. Progress in Neurobiology 85 (2008) 214-235
19. Carlsson T., Carta M., Munoz A., Mattsson B., Winkler C., Kirik D., et al. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain 132 (2009) 319-335
20. Carlsson T., Carta M., Winkler C., Bjorklund A., and Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. The Journal of Neuroscience 27 (2007) 8011-8022
21. Chung S., Shin B.S., Hedlund E., Pruszak J., Ferree A., Kang U.J., et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. Journal of Neurochemistry 97 (2006) 1467-1480
22. Chung S., Sonntag K.C., Andersson T., Bjorklund L.M., Park J.J., Kim D.W., et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. The European Journal of Neuroscience 16 (2002) 1829-1838
23. Dahlstrom A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica. Supplementum 62 232 (1964) 231-255
24. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 Pt 8 (1999) 1437-1448
25. 3H]dopamine uptake. Experimental Brain Research 77 (1989) 552-568
26. Dunnett S.B., Bjorklund A., and Lindvall O. Cell therapy in Parkinson's disease: stop or go?. Nature Reviews Neuroscience 2 (2001) 365-369
27. Dunnett S.B., Bjorklund A., Schmidt R.H., Stenevi U., and Iversen S.D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiologica Scandinavica. Supplementum 522 (1983) 29-37
28. Dunnett S.B., Hernandez T.D., Summerfield A., Jones G.H., and Arbuthnott G. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Experimental Brain Research 71 (1988) 411-424
29. Ekstrand M.I., Terzioglu M., Galter D., Zhu S., Hofstetter C., Lindqvist E., et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 1325-1330
30. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. The Journal of Comparative Neurology 180 (1978) 545-580
31. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 Pt 5 (1991) 2283-2301
32. Ferrari D., Sanchez-Pernaute R., Lee H., Studer L., and Isacson O. Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. The European Journal of Neuroscience 24 (2006) 1885-1896
33. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. The New England Journal of Medicine 344 (2001) 710-719
34. Friling S., Andersson A., Thompson L.H., Jonsson M., Hebsgaard J.B., Nanou E., et al. Efficient production of midbrain dopamine neurons by Lmx1a expression in embryonic stem cells. PNAS 106 18 (2009) 7613-7618
35. Fukuda H., Takahashi J., Watanabe K., Hayashi H., Morizane A., Koyanagi M., et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24 (2006) 763-771
36. Gage F.H., Stenevi U., Carlstedt T., Foster G., Bjorklund A., and Aguayo A.J. Anatomical and functional consequences of grafting mesencephalic neurons into a peripheral nerve "bridge" connected to the denervated striatum. Experimental Brain Research 60 (1985) 584-589
37. Gaillard A., Prestoz L., Dumartin B., Cantereau A., Morel F., Roger M., et al. Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nature Neuroscience 10 (2007) 1294-1299
38. Gates M.A., Coupe V.M., Torres E.M., Fricker-Gates R.A., and Dunnett S.B. Spatially and temporally restricted chemoattractive and chemorepulsive cues direct the formation of the nigro-striatal circuit. The European Journal of Neuroscience 19 (2004) 831-844
39. Geffen L.B., Jessell T.M., Cuello A.C., and Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature 260 (1976) 258-260
40. Gerfen C.R., and Wilson C.J. The basal ganglia. In: Bjorklund A., Hokfelt T., and Swanson L.W. (Eds). Handbook of chemical neuroanatomy, intergrated systems of the CNS, part III (1996), Elsevier, Amsterdam 371-468
41. German D.C., Manaye K., Smith W.K., Woodward D.J., and Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Annals of Neurology 26 (1989) 507-514
42. German D.C., and Manaye K.F. Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat. The Journal of Comparative Neurology 331 (1993) 297-309
43. German D.C., Manaye K.F., Sonsalla P.K., and Brooks B.A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Annals of the New York Academy of Sciences 648 (1992) 42-62
44. Hedlund E., Pruszak J., Lardaro T., Ludwig W., Vinuela A., Kim K.S., et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26 (2008) 1526-1536
45. Hidalgo A., and Brand A.H. Targeted neuronal ablation: the role of pioneer neurons in guidance and fasciculation in the CNS of Drosophila. Development 124 (1997) 3253-3262
46. Hornykiewicz, O. (1975). Brain monoamines and parkinsonism. National Institute on Drug Abuse Research Monograph Series, 13-21.
47. Isacson O., and Deacon T.W. Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 75 (1996) 827-837
48. Isacson O., Deacon T.W., Pakzaban P., Galpern W.R., Dinsmore J., and Burns L.H. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nature Medicine 1 (1995) 1189-1194
49. Jacobs F.M., Smits S.M., Noorlander C.W., von Oerthel L., van der Linden A.J., Burbach J.P., et al. Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 134 (2007) 2673-2684
50. Jonsson, M., Ono, Y., Bjorklund, A., and Thompson, L. H. (2009). Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Experimental Neurology, in press.
51. Kele J., Simplicio N., Ferri A.L., Mira H., Guillemot F., Arenas E., et al. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133 (2006) 495-505
52. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
53. Kirik D., Winkler C., and Bjorklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. The Journal of Neuroscience 21 (2001) 2889-2896
54. Klose M., and Bentley D. Transient pioneer neurons are essential for formation of an embryonic peripheral nerve. Science 245 (1989) 982-984
55. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. The Journal of Comparative Neurology 370 (1996) 203-230
56. Kuan W.L., Lin R., Tyers P., and Barker R.A. The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. Neurobiology of Disease 25 (2007) 594-608
57. Ledda F., Paratcha G., and Ibanez C.F. Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 36 (2002) 387-401
58. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., and McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature Biotechnology 18 (2000) 675-679
59. Li Y., and Raisman G. Long axon growth from embryonic neurons transplanted into myelinated tracts of the adult rat spinal cord. Brain Research 629 (1993) 115-127
60. Liang C.L., Sinton C.M., Sonsalla P.K., and German D.C. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5 (1996) 313-318
61. Lin D.M., Auld V.J., and Goodman C.S. Targeted neuronal cell ablation in the Drosophila embryo: pathfinding by follower growth cones in the absence of pioneers. Neuron 14 (1995) 707-715
62. Lin L., and Isacson O. Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits. Stem Cells 24 (2006) 2504-2513
63. Lin L., Rao Y., and Isacson O. Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neurons. Molecular and Cellular Neurosciences 28 (2005) 547-555
64. Lindvall O., and Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx: The Journal of the American Society for Experimental NeuroTherapeutics 1 (2004) 382-393
65. Lindvall O., and Hagell P. Clinical observations after neural transplantation in Parkinson's disease. Progress in Brain Research 127 (2000) 299-320
66. Mahalik T.J., and Clayton G.H. Specific outgrowth from neurons of ventral mesencephalic grafts to the catecholamine-depleted striatum of adult hosts. Experimental Neurology 113 (1991) 18-27
67. Maingay M., Romero-Ramos M., Carta M., and Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiology of Disease 23 (2006) 522-532
68. Maxwell S.L., Ho H.Y., Kuehner E., Zhao S., and Li M. Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Developmental Biology 282 (2005) 467-479
69. McConnell S.K., Ghosh A., and Shatz C.J. Subplate neurons pioneer the first axon pathway from the cerebral cortex. Science 245 (1989) 978-982
70. McConnell S.K., Ghosh A., and Shatz C.J. Subplate pioneers and the formation of descending connections from cerebral cortex. The Journal of Neuroscience 14 (1994) 1892-1907
71. McRitchie D.A., Cartwright H.R., and Halliday G.M. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease. Experimental Neurology 144 (1997) 202-213
72. McRitchie D.A., Hardman C.D., and Halliday G.M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. The Journal of Comparative Neurology 364 (1996) 121-150
73. Mendez I., Sadi D., and Hong M. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. The Journal of Neuroscience 16 (1996) 7216-7227
74. Mendez I., Sanchez-Pernaute R., Cooper O., Vinuela A., Ferrari D., Bjorklund L., et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128 (2005) 1498-1510
75. Molnar Z., Adams R., and Blakemore C. Mechanisms underlying the early establishment of thalamocortical connections in the rat. The Journal of Neuroscience 18 (1998) 5723-5745
76. Molnar Z., Adams R., Goffinet A.M., and Blakemore C. The role of the first postmitotic cortical cells in the development of thalamocortical innervation in the reeler mouse. The Journal of Neuroscience 18 (1998) 5746-5765
77. Molnar Z., and Blakemore C. Lack of regional specificity for connections formed between thalamus and cortex in coculture. Nature 351 (1991) 475-477
78. Mukhida K., Baker K.A., Sadi D., and Mendez I. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. The Journal of Neuroscience 21 (2001) 3521-3530
79. Nakamura S., Ito Y., Shirasaki R., and Murakami F. Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis. The Journal of Neuroscience 20 (2000) 4112-4119
80. Neuhoff H., Neu A., Liss B., and Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. The Journal of Neuroscience 22 (2002) 1290-1302
81. Nieoullon A., Cheramy A., and Glowinski J. Release of dopamine in vivo from cat substantia nigra. Nature 266 (1977) 375-377
82. Nikkhah G., Bentlage C., Cunningham M.G., and Bjorklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. The Journal of Neuroscience 14 (1994) 3449-3461
83. Nikkhah G., Duan W.M., Knappe U., Jodicke A., and Bjorklund A. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 56 (1993) 33-43
84. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., and Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 4245-4250
85. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Letters 407 (1997) 313-319
86. Olanow C.W., and Fahn S. Fetal nigral transplantation as a therapy for Parkinson's disease. In: Olanow C.W., and Brundin P. (Eds). Restorative therapies in Parkinson's disease (2006), Springer Science and Business Media, New York 93-118
87. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Annals of Neurology 54 (2003) 403-414
88. Olanow C.W., Gracies J.M., Goetz C.G., Stoessl A.J., Freeman T., Kordower J.H., et al. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Movement Disorders 24 (2009) 336-343
89. Olsson M., Nikkhah G., Bentlage C., and Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. The Journal of Neuroscience 15 (1995) 3863-3875
90. Ono Y., Nakatani T., Sakamoto Y., Mizuhara E., Minaki Y., Kumai M., et al. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 134 (2007) 3213-3225
91. Osborne P.B., Halliday G.M., Cooper H.M., and Keast J.R. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents. Neuroscience 131 (2005) 671-681
92. Paratcha G., and Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends in Neuroscience 31 (2008) 384-391
93. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 12543-12548
94. Pittman A.J., Law M.Y., and Chien C.B. Pathfinding in a large vertebrate axon tract: isotypic interactions guide retinotectal axons at multiple choice points. Development 135 (2008) 2865-2871
95. Pruszak J., Sonntag K.C., Aung M.H., Sanchez-Pernaute R., and Isacson O. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 25 (2007) 2257-2268
96. Robertson G.S., Damsma G., and Fibiger H.C. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. The Journal of Neuroscience 11 (1991) 2209-2216
97. Robertson G.S., Fine A., and Robertson H.A. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Brain Research 539 (1991) 304-311
98. Robertson H.A. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends in Neuroscience 15 (1992) 201-206
99. Rodriguez M., Barroso-Chinea P., Abdala P., Obeso J., and Gonzalez-Hernandez T. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease. Experimental Neurology 169 (2001) 163-181
100. Rosales M.G., Martinez-Fong D., Morales R., Nunez A., Flores G., Gongora-Alfaro J.L., et al. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience 80 (1997) 803-810
101. Rosenblad C., Martinez-Serrano A., and Bjorklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75 (1996) 979-985
102. Rosenblad C., Martinez-Serrano A., and Bjorklund A. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82 (1998) 129-137
103. Sieber B.A., Kuzmin A., Canals J.M., Danielsson A., Paratcha G., Arenas E., et al. Disruption of EphA/ephrin: a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Molecular and Cellular Neurosciences 26 (2004) 418-428
104. Sinclair S.R., Fawcett J.W., and Dunnett S.B. Dopamine cells in nigral grafts differentiate prior to implantation. The European Journal of Neuroscience 11 (1999) 4341-4348
105. Sonntag K.C., Pruszak J., Yoshizaki T., van Arensbergen J., Sanchez-Pernaute R., and Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25 (2007) 411-418
106. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Research Bulletin 9 (1982) 321-353
107. Thompson L., Barraud P., Andersson E., Kirik D., and Bjorklund A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. The Journal of Neuroscience 25 (2005) 6467-6477
108. Thompson L.H., Andersson E., Jensen J.B., Barraud P., Guillemot F., Parmar M., et al. Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon. Experimental Neurology 198 (2006) 183-198
109. Thompson, L. H., Grealish, S., Kirik, D., and Bjorklund, A. (2009). Re-construction of the nigro-striatal dopamine pathway in the adult mouse brain. The European Journal of Neuroscience, in press.
110. Thompson L.H., Kirik D., and Bjorklund A. Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain. Experimental Neurology 213 (2008) 220-228
111. Torres E.M., Monville C., Gates M.A., Bagga V., and Dunnett S.B. Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease. Neuroscience 146 (2007) 1606-1617
112. Trupp M., Belluardo N., Funakoshi H., and Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. The Journal of Neuroscience 17 (1997) 3554-3567
113. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 105 (2008) 5856-5861
114. Wictorin K., Brundin P., Sauer H., Lindvall O., and Bjorklund A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. The Journal of Comparative Neurology 323 (1992) 475-494
115. Wictorin K., Lagenaur C.F., Lund R.D., and Bjorklund A. Efferent projections to the host brain from intrastriatal striatal mouse-to-rat grafts: time course and tissue-type specificity as revealed by a mouse specific neuronal marker. The European Journal of Neuroscience 3 (1991) 86-101
116. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., et al. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. The Journal of Neuroscience 19 (1999) 2301-2312
117. Winkler C., Bentlage C., Nikkhah G., Samii M., and Bjorklund A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Experimental Neurology 155 (1999) 165-186
118. Winkler C., Kirik D., Bjorklund A., and Dunnett S.B. Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Progress in Brain Research 127 (2000) 233-265
119. You Z.B., Nylander I., Herrera-Marschitz M., O'Connor W.T., Goiny M., and Terenius L. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-I. Effects of K(+)-depolarization, lesions and peptidase inhibition. Neuroscience 63 (1994) 415-425
120. Yue Y., Widmer D.A., Halladay A.K., Cerretti D.P., Wagner G.C., Dreyer J.L., et al. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. The Journal of Neuroscience 19 (1999) 2090-2101
121. Yurek D.M., and Fletcher-Turner A. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Research 891 (2001) 228-235
122. Zhou J., Pliego-Rivero B., Bradford H.F., and Stern G.M. The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Brain Research. Developmental Brain Research 97 (1996) 297-303